BTI
DNA icon

Blue Trust Inc’s Ginkgo Bioworks DNA Stock Holding History

Blue Trust Inc’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,129
Closed -$712 – 2578
2024
Q3 		$712 Buy
2,129
+2,013
+1,735% +$20.2K ﹤0.01% 2753
2024
Q2 		$5.37K Buy
+116
New +$3.46K ﹤0.01% 2180
2024
Q1 		– Sell
-91
Closed -$7K – 2318
2023
Q4 		$7K Buy
+91
New +$5.57K ﹤0.01% 1701
2023
Q2 		– Sell
-42
Closed -$3K – 2129
2023
Q1 		$3K Buy
42
+20
+91% +$1.27K ﹤0.01% 1905
2022
Q4 		$2K Buy
+22
New +$2.02K ﹤0.01% 1912

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Blue Trust Inc's DNA Position: Q4 2024 in Review

Blue Trust Inc sold out of Ginkgo Bioworks (DNA) in Q4 2024, closing a stake of 2,129 shares — an estimated $712 sold.

Blue Trust Inc first reported a position in DNA in Q4 2022 and held it in 5 quarters. The position peaked at $7K in Q4 2023. 166 funds tracked by Wall St. Rank hold DNA as of Q4 2024.

  • Blue Trust Inc reported no remaining Ginkgo Bioworks position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 2,129 Ginkgo Bioworks shares in Q4 2024, an estimated $712.
  • Blue Trust Inc first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 5 quarters.
  • Blue Trust Inc's Ginkgo Bioworks position peaked at $7K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.